ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
278.77
1.55
(0.56%)
Closed 24 April 6:00AM
293.55
14.78
(5.30%)
After Hours: 8:54AM

Calls

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
195.000.000.000.000.000.000.00 %00-
200.0078.5081.300.0079.900.000.00 %00-
210.0068.8071.300.0070.050.000.00 %00-
220.000.000.000.000.000.000.00 %00-
230.000.000.000.000.000.000.00 %00-
240.000.000.000.000.000.000.00 %00-
250.0031.0036.0025.8033.500.000.00 %02-
260.0023.5028.5028.9026.003.4013.33 %1524/4/2025
270.0017.0022.0022.1519.504.2523.74 %8141724/4/2025
280.000.000.000.000.000.000.00 %00-
290.000.000.000.000.000.000.00 %00-
300.000.000.000.000.000.000.00 %00-
310.002.756.104.604.425-0.65-12.38 %308224/4/2025
320.000.000.000.000.000.000.00 %00-
330.001.053.700.002.3750.000.00 %00-
340.000.502.851.001.6750.000.00 %2024/4/2025
350.000.152.250.001.200.000.00 %00-
360.000.000.000.000.000.000.00 %00-
370.000.000.000.000.000.000.00 %00-
380.000.002.250.000.000.000.00 %00-

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Puts

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
195.000.000.000.000.000.000.00 %00-
200.000.102.950.001.5250.000.00 %00-
210.000.103.201.081.650.000.00 %4024/4/2025
220.000.000.000.000.000.000.00 %00-
230.000.000.000.000.000.000.00 %00-
240.001.605.303.523.45-1.18-25.11 %301224/4/2025
250.002.507.205.374.85-2.43-31.15 %4124/4/2025
260.000.000.000.000.000.000.00 %00-
270.000.000.000.000.000.000.00 %00-
280.000.000.000.000.000.000.00 %00-
290.0018.5023.500.0021.000.000.00 %00-
300.0025.5030.500.0028.000.000.00 %00-
310.0033.0037.800.0035.400.000.00 %00-
320.0042.0046.300.0044.150.000.00 %00-
330.0051.3055.300.0053.300.000.00 %00-
340.000.000.000.000.000.000.00 %00-
350.0070.4074.400.0072.400.000.00 %00-
360.0080.2084.300.0082.250.000.00 %00-
370.000.000.000.000.000.000.00 %00-
380.0099.50104.00112.60101.750.000.00 %00-

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SPWRComplete Solaria Inc
US$ 1.975
(1,508.31%)
527.37k
JYDJayud Global Logistics Ltd
US$ 0.2665
(161.27%)
413.86M
ENSCEnsysce Biosciences Inc
US$ 3.64
(94.65%)
92.03M
AGMHAGM Group Holdings Inc
US$ 0.0562
(87.33%)
732.69M
RLMDRelmada Therapeutics Inc
US$ 0.6758
(78.78%)
33.53M
VINCVincerx Pharma Inc
US$ 0.0456
(-83.42%)
891.75k
OCEAOcean Biomedical Inc
US$ 0.0204
(-47.01%)
171.47M
CTHRCharles and Colvard Ltd
US$ 0.535
(-34.63%)
694.9k
INTSIntesity Therapeutics Inc
US$ 1.2993
(-31.97%)
574.96k
ELPWElong Power Holding Ltd
US$ 2.69
(-30.76%)
246.8k
AGMHAGM Group Holdings Inc
US$ 0.0562
(87.33%)
732.69M
JYDJayud Global Logistics Ltd
US$ 0.2665
(161.27%)
413.86M
DMNDamon Inc
US$ 0.00405
(3.85%)
351.98M
NVDANVIDIA Corporation
US$ 102.71
(3.86%)
246.18M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 8.18
(10.69%)
231.75M

PEN Discussion

View Posts
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
... ALL NEWS IS GOOD? ... $PEN



CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company
👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients
👍️0
davidsson10 davidsson10 4 years ago
https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link
👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020
👍️0
TREND1 TREND1 10 years ago
IPO INFO

http://www.marketwatch.com/tools/ipo-calendar
👍️0
TREND1 TREND1 10 years ago
IPO NOW HAS SYMBOL
Penumbra PEN
👍️0
TREND1 TREND1 10 years ago
IPO should be out soon.
no symbol yet.
👍️0